Abstract
This study considered the Sustainable Development Goals (SDG) Index, Human Development Index (HDI), and Environmental Performance Index (EPI) as sustainability indexes and explored their potential effectiveness as predictors of Covid-19 excess mortality among countries in the Organization for Economic Cooperation and Development (OECD). The results indicated strong negative correlations between each index and Covid-19 excess mortality. Each of the indexes was able to consistently predict variations in excess mortality in the regression models. Such findings contribute to the current discussion on what lessons we should take away from the Covid-19 pandemic, specifically whether sustainability indexes may be useful in assessing Covid-19 outcomes. It is valuable to further examine the role sustainable policies and practices can play in preparing for future crises, as it has been demonstrated that social, economic, and environmental factors influenced the ability of a country to mitigate the impact of Covid-19. Overall, the most effective way for a country to both prevent and prepare for the next crisis is to improve health, education, and standard of living for its people, protect the environment, and achieve sustainability.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author declares he has no actual or potential competing financial interests.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
liulee2007{at}hotmail.com
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.